Share on LinkedInShare on LinkedIn

ARTICLE · 13 FEBRUARY 2006

The Monsanto Row

Transgenic crops have always been the topics of hot controversial debates. The genetic alteration by the insertion of the genetic material containing the code for desired phenotypic expressions from another species confers some beneficial characteristics in the created crops.

IndiaIntellectual Property

Transgenic crops have always been the topics of hot controversial debates. The genetic alteration by the insertion of the genetic material containing the code for desired phenotypic expressions from another species confers some beneficial characteristics in the created crops. The case of Bt (Bacillus thuringiensis) cotton is a perfect example of the complex challenge regarding IPR and commercial property rights in the case of seeds and plants. On October 31, 1995 Monsanto got final approval for the commercial sale of its genetically modified cottonseed Bolgard engineered to produce its own insecticide. The seed contains a gene that codes for Bt, a naturally occurring soil bacterium that produces proteins that are toxic to many larvae of the lepidoptera order. Monsanto holds patents for this technology.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from